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Background/aim: To study the effect of kisspeptin, a gonadotropin release stimulator, on the testicular tissue of the rat.
Materials and methods: Four groups were formed as follows: control, Kiss-10 50 nmol administration for 1 day, Kiss-10 administration
for 13 days, and one last group kept for 7 days following Kiss-10 applied for 13 days. Testicular tissues were stained with hematoxylineosin, periodic acid Schiff, Masson trichrome staining, terminal deoxynucleotidyl transferased UTP nick-end labeling, and Ki-67
immune staining. Serum testosterone levels were determined.
Results: Serum testosterone level increased following acute application, while it was reduced by chronic treatment. Spermatogenic
cells as stained by Ki-67 and TUNEL increased in the treated groups compared to the controls. Following a 7-day rest after treatment,
a decrease in testosterone levels and Ki-67–stained cell numbers and an increase in TUNEL-stained cells were observed. Leydig cells
showed increased vacuolization in the Kiss-1 group. Leydig cell vacuolization continued in the Kiss (13) group and was reduced in the
Kiss (13 + 7) group.
Conclusion: Kiss-10 increased spermatogenic cell proliferation, while testosterone level and proliferation decreased and apoptosis
increased during the waiting period.
Key words: Kisspeptin, spermatogenesis, apoptosis, Leydig cells

1. Introduction
Kisspeptins, the peptide products of the KiSS-1 gene, bind
to the G protein-coupled receptor 54 (GPR54), a critical
regulator of GnRH secretion. The N-terminally truncated
peptide metastin 45-54 exhibits 10-fold higher receptorbinding affinity than full-length metastin; it also shows
agonistic KISS-1R activity (1).
Kisspeptins are known to play a role in puberty,
cancer metastasis, and vasoconstriction (2,3–7).
They are synthesized in the arcuate and anteroventral
periventricular hypothalamic neurons and in the perioptic
area (8). Kisspeptin expression is variable according
to sex in rats; its expression is more marked in female
animals (9). Its known derivatives are kisspeptin-10,
kisspeptin-13, kisspeptin-14, and kisspeptin-54 (10–
12). All kisspeptins seem to have the same interactions
under in vitro conditions. Kiss-10 is well characterized
* Correspondence: akukner@hotmail.com
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in mammals, in which it is found in large concentrations
(10,11). It has been suggested, however, that Kiss-54 is the
most effective form (12). Kisspeptin has been reported to
also be synthesized in the testes, ovaries, pancreas, gut,
liver, lung, muscle tissue, kidney, nervous system, and
most densely in the placenta (13,14). As for its receptor, G
protein-coupled receptor-54 (GPR54) is mostly expressed
in the hypophysis, placenta, and pancreas (10,15,16).
Kisspeptins are highly potent neuropeptides that stimulate
the secretion of LH and FSH from the hypophysis, an
effect exerted through the release of GnRH (7,17). While
this pathway has been satisfactorily defined in several
mammal species, the molecular and cellular events at
the proencephalic origin of this process are incompletely
elucidated. In recent years, studies have indicated that
kisspeptin plays a role in the transition to puberty (18,19).
Kiss-1 knockout mice showed hypogonadism and low
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levels of circulating gonadotropin (20,21). Kisspeptin
has been shown to control seasonal fertility in sheep (22)
and hamsters (23,24). A literature search revealed only a
limited number of studies on the effects of kisspeptin.
The aim of the present study was to study the
structural and biochemical effects of acute and chronic
kisspeptin administration on seminiferous tubular cells,
spermatogenesis, apoptosis, and Leydig cells and the
reversibility of such effects.
2. Materials and methods
2.1. Experimental animals
All experimental protocols were performed according to
the guidelines for the ethical treatment of experimental
animals and were approved by the Animal Care and Use
Local Ethics Committee. Eight-week-old male Wistar
albino rats (200–230 g) were housed at a constant room
temperature (21 ± 2 °C) under a 12-h light/dark cycle.
They were fed standard rat chow (210 kcal/100 g per day)
and drank tap water.
Twenty-four male Wistar rats weighing 200–300 g
were used in the study. Four groups were constructed:
Control group (n = 6): Received intraperitoneal normal
saline only.
Kiss (1) (n = 6): Kiss-10 [metastin (45-54) amide,
M2816-1MG, SIGMA], 50 nmol, intraperitoneally was
given once to these animals.
Kiss (13) (n = 6): These animals received Kiss-10,
50 nmol, intraperitoneally daily for 13 days.
Kiss (13 + 7) (n = 6): After receiving Kiss-10, 50 nmol,
intraperitoneally daily for 13 days, these animals were
kept for 7 days without any treatment. Kisspeptin-10
was used because it is the minimal sequence required for
full receptor binding and activation (10,11). The single
injection treatment was defined as acute and the 13-day
treatment as chronic. The rats were weighed before the
study and at its termination. Testes were removed and
weighed. Gonadosomatic index percent (GSI %) was
determined using the following formula (25):
GSI (%) = Testes weight × 100
Body weight
2.2. Biochemistry
Blood was drawn under anesthesia from the inferior vena
cava, centrifuged at 1000 × g for 20 min, and kept at –20 °C.
Total testosterone level was measured using an ELISA kit
(USCN Life Science Inc., Wuhan, E90458Ra, L101101379,
P.R. China). The measurement was performed following
the instructions provided with the kit.
2.3. Light microscopy
The left testes were fixated in a 10% solution of neutral
formalin. The right testes were frozen at –96 °C to
examine with immunofluorescence microscopy. Blocks

were prepared after routine preparation. Sections were
stained with hematoxylin-eosin, periodic acid Schiff
(PAS), and Masson’s trichrome methods; the diameters
of the seminiferous tubules were measured. Staining with
Ki-67 was performed (9106S1003B, Thermo Scientific,
USA) for marking proliferating cells and with terminal
deoxynucleotidyl transferased UTP nick-end labeling
(TUNEL) (ApopTag Plus Peroxidase In Situ Apoptosis
Detection Kit, S7101, Chemicon International; Lot
PSO1736498) for apoptotic cells. The numbers of apoptotic
and proliferating cells were determined by counting
stained dark-brown nuclei in 10 cross-sectional fields of
seminiferous tubules per testis section. Tissues were frozen
at –96 °C for immune fluorescence determination of Kiss10 expression. Sections 15-µm thick obtained by a freezing
microtome were stained using a Kiss-1 antibody [(C-20),
goat polyclonal IgG, #H1910, Santa Cruz Biotechnology,
Inc., Dallas, TX, USA] and examined under an immune
fluorescence microscope.
2.4. Electron microscopy
Tissues were taken and fixed in 2.5% glutaraldehyde in
0.1 M sodium phosphate buffer (pH 7.2) for 24 h. After
rinsing with phosphate buffer, tissues were postfixed
with 2% osmium tetroxide in sodium phosphate buffer.
Dehydration was accomplished by gradual ethanol series
and embedded in epoxy resin. Semithin sections (1 µm)
were stained toluidine blue. Sections were then viewed and
photographed with light microscopy.
2.5. Statistical evaluation
The study data were evaluated using GraphPad Prism
software (version 3.00, GraphPad Software, La Jolla, CA,
USA). The Kruskal–Wallis test was used for betweengroup comparison of apoptotic and Ki-67(+) cell counts
and Dunn’s multiple comparison test for within-group
evaluations. Subject weights, testosterone levels, testis
weights, gonadosomatic index (GSI %), and tubular
diameters were evaluated by the Mann–Whitney U test.
Biochemical measurements were compared using oneway ANOVA, while within-group comparisons used
Tukey’s test. P-values smaller than 0.05 were accepted as
significant.
3. Results
There was no difference in body weight, testicular weight,
GSI %, or diameter of seminiferous tubules among the
groups. Kiss-1 immune positive cells were not detected in
any group (data not shown).
3.1. Serum testosterone levels
While serum testosterone levels were significantly elevated
after a single administration of kisspeptin (P < 0.03) they
decreased in the Kiss (13) and Kiss (13 + 7) groups,
although with no significant difference from the controls
(Figure 1).
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Figure 1. Plasma testosterone levels. *P < 0.03 compared to other groups.

3.2. Proliferating cell count
Ki-67 immune staining was applied to determine the
number of proliferative cells in the seminiferous tubules.
The Ki-67–stained spermatogenic cells were counted for
all groups. Ki-67–stained cell counts were higher in the
Kiss (13) group compared to both Kiss (1) and the controls
(P < 0.001). As for the (13 + 7) group, after a 7-day rest
following 13 consecutive days of treatment, the stained cell
count was higher than that in both the controls and Kiss
(1) (P < 0.001 and 0.01, respectively) but lower than that of
Kiss (13). No statistical significance was detected between
the Kiss (13) and Kiss (13 + 7) groups (Figure 2).
3.3. Apoptotic cell count
TUNEL staining was applied to mark apoptotic cells in the
seminiferous tubules. TUNEL (+)-stained spermatogenic
cells were counted in all groups (Figure 3).
A lower number of TUNEL (+) cells were detected in
the Kiss (1) group, but the difference was not significant.
Apoptotic TUNEL (+) cell counts were significantly higher
in the Kiss (13) and Kiss (13 + 7) groups compared to the
controls (P < 0.05) and Kiss (1) (P < 0.001).
3.4. Light microscopy findings
Kisspeptin expression was not observed in either the
control or the treatment groups
(data not shown). Seminiferous tubules in treated
animals were largely similar to those of the control group
(Figures 4a–4d). Cell shedding was present but not
widespread in the lumens of some tubules in the treatment
groups. Tissues from all groups were stained with PAS.
No disruption or thickening of the basal membrane was
seen with PAS staining in the treatment groups. Staining
intensity was comparable throughout all animal groups.
Connective tissue proliferation among seminiferous
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tubules was not observed following Masson trichrome
staining (data not shown).
The appearance of Sertoli and Leydig cells,
spermatogonia, primary spermatocytes, spermatids,
developing acrosomes, and spermatozoa was by definition
normal for the control group (Figure 5a). The seminiferous
tubule basal membrane was markedly corrugated in the
Kiss (1) group, where vacuolization in the Sertoli cells
and spermatocytes, increased intercellular intervals, and
numerous vacuoles in Leydig cells were observed (Figure
5b). Leydig cell vacuolization continued in the Kiss (13)
group (Figure 5c). In the Kiss (13 + 7) group, such vacuoles
in the Leydig cells were fewer; excessive intercellular
distances remained (Figure 5d).
The cells that stained positive with Ki-67 were generally
identified as spermatogonia. No immune staining was
found in Leydig or Sertoli cells. Mitotic activity was least
in the controls and highest in the Kiss (13) group (Figures
6a–6d).
TUNEL (+)-stained cells, the spermatogonia, were very
few in the controls and more abundant in the treatment
groups. TUNEL (+) immune staining was not observed in
the Sertoli or Leydig cells (Figures 7a–7d).
4. Discussion
Since 2003, research has revealed the important role
of kisspeptins in initiation and timing of puberty
and in regulating fertility in adulthood. Continuous
administration of kisspeptins downregulates the
hypothalamic–gonadal–pituitary (HPG) axis (26).
Kisspeptin is a potent peptide that initiates luteinizing
hormone (LH) release in male and female mice (27), in both
prepubertal and adult rats (28) and in prepubertal donkeys
(29). Plasma LH and testosterone levels were reported to
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Figure 2. Number of Ki-67(+) cells. Ki-67 staining cells in the acute treatment, Kiss (1) (*), chronic treatment Kiss (13)
(**) and additional waiting period
Kiss (13 + 7) (***) groups were statistically significantly higher than in the control group (P < 0.001)
*Control vs. Kiss (1) group, P < 0.001
**Control vs. Kiss (13) group, P < 0.001
***Control vs. Kiss (13 + 7) group, P <0.001
#Kiss (1) vs. Kiss (13) group, P < 0.001
##Control vs. Kiss (13 + 7) group, P <0.01

Figure 3. Apoptotic TUNEL (+) cell counts were significantly higher in the Kiss (13) and Kiss (13 + 7) groups
compared to the controls (*P < 0.05) and Kiss (1) (**P < 0.001).
*Control vs. Kiss (13) group, P < 0.05
***Control vs. Kiss (13 + 7) group, P < 0.05
**Kiss (1) vs. Kiss (13) group, P < 0.001
**Kiss (1) vs. Kiss (13 + 7) group, P < 0.001
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Figure 4. Light microscopic view of seminiferous tubules in experimental groups. The seminiferous tubules structure can
be seen to resemble each other. Control (4a), Kiss (1) (4b), Kiss (13) (4c), and Kiss (13 + 7) (4d) groups. Hematoxylin and
eosin stain.

be increased on the day following the first administration
of Kisspeptin-54 (50 nmol/day), an effect that disappeared
after the second day of treatment, when hormone levels
returned to normal. This result was interpreted as being
due to desensitization of the HPG axis by the continuous
use of kisspeptin (12). A single dose of Kiss-54 was
reported to cause ovulation in rats (30) and to significantly
increase sex steroid levels in prepubertal fish (31).
Gonadotropin increases were registered following a single
IV or IM dose of Kiss-10 in prepubertal cats (32), sheep
(33), and goats (34). It was reported that Kiss-10 given at
varying doses reduces testosterone levels, a reduction that
was attributed to testicular degeneration rather than a fall
in LH secretion (25). However, another published study
indicated that different doses of Kiss-10 were all followed
by a testosterone increase within 20 min of administration
(35). We observed that Kiss-10 significantly increased
total testosterone plasma levels in the acute phase while
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chronic administration was associated with a decrease,
which continued in the additional waiting period without
reaching the control levels. The increased vacuolization in
the Leydig cells was interpreted as a possible enlargement
of endoplasmic reticulum, consistent with active secretion.
Kisspeptin mRNA, characterized in human testicular
tissue (11), was not identified in rat testes (36). Wang et al.
reported that Kiss-10 expression is strong in Leydig cells of
5-week- and 15-week-old mice, while it is weak in 2-weekold mice (37). Salehi et al., while observing Kisspeptin
expression in Leydig cells, found no development in germ
cells or Sertoli cells at any stage (38). We did not detect
any positive immune staining for Kiss-1 in any group in
our study.
Kisspeptins were reported to have a predominately
autocrine and paracrine action in the testes (39,40).
Our results are similar to those reported by Thompson
et al. in that testosterone levels decreased over a 13-day
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Figure 5. Semithin section view of experimental groups. Seen intact spermatogenic and Sertoli cells in the control group (5a). More
folding basement membrane, many vacuoles in the Sertoli and Leydig cell cytoplasm are seen in the Kiss (1) group (5b). Increased
vacuoles in the Leydig cells cytoplasm of the Kiss (13) group (5c) and decreased vacuoles in the Leydig cells cytoplasm of the Kiss (13 +
7) group (5d) are seen. Sp: Spermatid, Ps: Primary spermatocytes, SC: Sertoli cells, LC: Leydig cells. Toluidine blue stain.

Figure 6. Ki-67 immunohistochemistry stained view of groups. Control (6a), Kiss (1) (6b), Kiss (13) (6c), and Kiss (13 + 7) (6d) groups.
Ki-67-positive–stained spermatogenic cells of Kiss (1) and Kiss (13) groups are increased compared to the control and Kiss (13 + 7)
groups.
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Figure 7. TUNEL-positive staining in spermatogenic cells in the Kiss (13 + 7) group is higher than the other groups.
Control (7a), Kiss (1) (7b), Kiss (13) (7c), Kiss (13 + 7) (7d) groups.

treatment period and adult male rats were used (12,39).
The increase seen in Ki-67–stained spermatogonia within
the seminiferous tubules in our study was interpreted
as related to the increase in testosterone levels; their
proliferation increased with both acute and chronic
treatment and decreased in the additional waiting period
without, however, reaching control levels. This finding was
attributed to the reversibility of Kiss-10 action.
A twice-weekly high-dose (250 ng/g) Kiss-10 treatment
for 7 weeks increased the GSI of prepubertal white bass,
while no significant change could be detected in striped
bass (41). Another report indicated that Kiss-15 increases
GSI in prepubertal fish (31). Reports vary according
to subject type and physiological development stages.
Varying stimuli have been determined for different modes
of administration (central or systemic) and different
physiological stages (42,43). Kisspeptin-54, 50 nmol daily
for 13 days, led to testicular degeneration in adult rats
(12,39). Application of Kiss-10 led to seminiferous tubule
degeneration in prepubertal rats; cellular degeneration was
seen to increase along with increasing dose. Cytoplasmic
vacuolization was demonstrated by light and electron
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microscopy in Sertoli cells and spermatogonia (25). In our
study, no obvious degeneration was observed in seminiferous
tubule cells even though the dose administered amounted
to 50 nmol; in contrast, the increased testosterone level
increased spermatogenesis. While apoptotic spermatogonia
were identified in our study, no apoptosis was seen in the
Sertoli or Leydig cells. Semithin sections showed a large
degree of cytoplasmic vacuolization in the Sertoli cells
and spermatogonia. Vacuolization decreased in the cells
of animals in the groups subjected to chronic treatment
and in those with the additional waiting period. Apoptotic
cell counts were low in the acute treatment animals and
increased in the two other treatment groups. The increase
in Ki-67 staining cells in acute treatment animals paralleled
the increase in testosterone level. However, proliferation
increased in chronic treatment animals despite the
testosterone decrease. The increased apoptotic cell count
was possibly offsetting the increase in total cell count
that occurred over the same period. Testosterone levels
continued to decrease, apoptosis counts increased, and
proliferation of spermatogenic cells decreased over the
7-day waiting period following chronic administration.
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To summarize, acute or chronic administration of
50 nmol/kg kisspeptin-10 was not observed to cause
degeneration in the rat seminiferous tubules, while
it increased cellular proliferation; the interruption of
kisspeptin was associated with a decrease in proliferation
and testosterone levels and with an increase in apoptosis.
Kiss-10 was seen to exert its effects through testosterone

secretion; these effects were reversible. The increased
proliferation in spermatogenic cells may lead to new
developments in the treatment of infertility.
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